Skip to content

Developement of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin

Developement of Prognosis Predictive Precision Medicine Based on a Digital Twin Reflecting the Motor Patterns in Stroke Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06035198
Enrollment
1192
Registered
2023-09-13
Start date
2023-10-05
Completion date
2025-12-31
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The purpose of this study is to realize customized precision medicine for stroke patients and the visual digitization of patient medical information required in the era of digital transformation. This study will collect large-scale, high-quality clinical data and daily life exercise pattern data covering the subacute to chronic stages of stroke patients. Based on this, we will use artificial intelligence analysis technology to predict the functional status of stroke patients in the chronic stage after their disability is fixed. We aim to develop the next generation of personalized digital twins by creating a prognostic prediction model.

Interventions

OTHERStroke

No intervention

Sponsors

Seyoung Shin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over 20 years of age with a history of stroke onset between 2018.01.01 to 2023.07.31. * Patients who exist rehabilitation medical evaluation after stroke onset * Patients who voluntarily decide to participate in this study

Exclusion criteria

* Those who have severe internal diseases such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc. and are in poor overall condition. * Those who have impaired ability to consent (MMSE score less than 10 points) and not accompanied by a care-giver. * In any other cases where the researcher determines that participation in this study is not appropriate.

Design outcomes

Primary

MeasureTime frameDescription
Modified Barthel Index (MBI)minimum 6 months to maximum 6 yearsA scale to measure disability or dependence in activities of daily living (ADL) of stroke survivors (range 0-100)

Secondary

MeasureTime frameDescription
Mini Mental Status Examination (MMSE)minimum 6 months to maximum 6 yearsMini-Mental State Examination (MMSE) is a 30-question assessment of cognitive function that evaluates attention and orientation, memory, registration, recall, calculation, language and ability to draw a complex polygon (range 0-30)
Functional Ambulatory Category (FAC)minimum 6 months to maximum 6 yearsThe Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability, determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device. (range 0-5)

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORSeyoung Shin, MD

CHA University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026